Pantoprazol Braiter (Pantoprazole)

Pantoprazole blocks the H+/K+‑ATPase enzyme, commonly called the gastric proton pump, on the surface of stomach parietal cells. By irreversibly inhibiting this pump, it prevents the final step of acid secretion, leading to a sustained rise in gastric pH and reduced acidity that alleviates acid‑related damage.

The dosage of Pantoprazol Brauer is determined by the prescribing clinician based on the specific indication, patient age, renal function and treatment duration. Healthcare professionals set the appropriate strength and dosing schedule according to clinical guidelines and individual patient needs.

Pantoprazole is classified as pregnancy category B in many regions, indicating no evidence of risk in animal studies but limited human data. It should be used during pregnancy or lactation only if the potential benefit justifies the potential risk, and the decision should be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Pantoprazol Brauer belongs to the proton pump inhibitor class, which provides more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with other PPIs, pantoprazole has a lower potential for drug‑drug interactions mediated by CYP2C19, making it a suitable option for patients on multiple medications.

Store Pantoprazol Brauer tablets at temperatures below 25 °C in their original container, protected from moisture, heat and direct sunlight. Maintaining these conditions preserves the tablet’s stability and potency throughout its shelf life.

Pantoprazol Brauer is supplied as oral tablets that are taken with water. For optimal absorption, it is usually recommended to swallow the tablet whole, preferably before a meal, unless the prescribing clinician advises an alternative administration schedule.

Serious risks, though uncommon, include severe allergic reactions (anaphylaxis), Clostridioides difficile‑associated diarrhea, low magnesium levels, acute interstitial nephritis and increased risk of bone fractures with long‑term use. Patients should seek immediate medical attention if they experience symptoms such as rash, persistent diarrhea, muscle cramps or unexplained bone pain.

Pantoprazol Brauer is contraindicated in individuals with known hypersensitivity to pantoprazole or any other component of the formulation. Caution is also advised for patients with severe liver impairment, those taking certain interacting medications, and pregnant or breastfeeding women unless the benefits outweigh the risks.